Abstract. Catabolite repression is defined as the inhibition of enzyme induction by glucose or related substances. In the bacterium E. coli, the effect of glucose appears to be due to a lowering of the cyclic AMP level. A DNAdirected cell-free system for #3-galactosidase synthesis has served as a model system for studying the mechanism of action of cyclic AMP. Previously, it was reported that in this system cyclic AMP is required for normal initiation of mRNA synthesis. A protein factor which acts in conjunction with the cyclic AMP has been partially purified. This protein factor has a high affinity for cyclic AMP. These and other results presented herein lead us to the conclusion that cyclic AMP and a protein factor called the catabolite gene activator protein are part of a positive control system for activating catabolite-sensitive genes.
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Introduction. Catabolite repression involves the inhibition of enzyme induction by glucose or biochemically related compounds such as glucose 6-phosphatee, fructose, or glycerol.' The extent of inhibition, which varies from a few per cent to more than 90%, is dependent on the bacterial strain, the source of the catabolite, and the growth conditions. Enzymes which show the repression effect include enzymes of glycerol regulation, the gal operon, the arabinose operon, the lac operon, tryptophanase, D-serine deaminase, and histidase. In fact, most enzymes classified as inducible show some effect. Although observations on catabolite repression date back to the turn of the century,2 it is only recently that significant understanding of the mechanism of the reaction has been achieved.
For a long time the most serious impediment to progress was in determining, out of the multiplicity of effects of glucose, the ones which were directly linked to catabolite repression. A turning point in our understanding of this phenomenon was provided when Makman and Sutherland' showed that a rapid decrease in the intracellular level of cyclic 3': 5'-adenosine monophosphate (cyclic AMP) occurs in the presence of glucose. From that time on it has become increasingly clear that the glucose effect is due to a lowering of the cyclic AMP level. Thus Perlman and Pastan4 and Ullman and Monod5 showed that the repressing effect of glucose on the synthesis of enzymes could be reversed by the addition of cyclic AMP. Having determined that cyclic AMP plays a key role in catabolite repression, furrher understanding of the phenomenon requires that two questions be answered: (1) How does glucose control the cyclic AMP level and (2) How does cyclic AMP control the enzyme level? Our efforts are directed toward answering the second question.
Methods. (a) Isolation of E. coli strain X7901: The starting strain was CA-8000, an Hfr Hayes prototroph. After mutagenic treatment with nitrosoguanidine, approximately 500 bacteria are spread on tetrazolium agar containing arabinose and maltose. Mutants incapable of metabolizing the two carbon sources in the media give rise to red colonies with a frequency of about 0.5%. Most of the ara-malh are also lac-. Some of these show phenotypic reversion to lac+ in the presence of cyclic AMP, others do not. One of the latter (CA-7900) was crossed with an F-strain which was arg-, met B-, pyr F-, trp-, and arg+ met+ recombinants selected. One recombinant (X-7900) which was arg+ met+ trp+ pyr F-was selected for further crosses. An Hfr (CA-7033) carrying the lac-pro A, B deletion, X-111, was crossed with X-7900; pyr F+ trp-recombinants were selected and scored for the pro-character. A pro-trp-recombinant, (X7901), carrying the lac-pro deletion was isolated. This strain is ara-, mal-, lac-and is unaffected by cyclic AMP in the growth medium. Work to be reported elsewhere has shown that these deficiencies are due to a single gene alteration at a distant point from the operons.
(b) Procedures for ,B-galactosidase synthesis and assay: Except for slight modifications described herein, all procedures used for synthesis, enzyme assay, and preparation of bacterial extracts and DNA have been described in detail elsewhere. The procedures for synthesis and assay will be reviewed here. (d) Dialysis-binding studies: The partially purified CAP described above is concentrated to about 0.5% protein by burying a dialysis sac in G-200 Sephadex for 18 hr at 50C. Concentrated extract (0.7 ml) is placed in another dialysis sac and dialyzed for 18 hr against buffer I and the appropriate concentration of 'H-cyclic AMP. A 0.3-ml aliquot from inside and outside the dialysis sac are dissolved in 3 ml of formic acid; 1-ml aliquots are plated and counted in a windowless gas flow counter.
Results and Discussion. The direct involvement of cyclic AMP in triggering catabolite genes was made clearest by the finding that this compound is required in a DNA-directed cell-free system for normal initiations leading to the synthesis of the enzymes of the lac operon. Since normal initiation of mRNA synthesis occurs at the promoter locus of the operon, it seems likely that cyclic AMP or a closely related derivative interacts at this gene site.9 This stimulatory action of cyclic A\IP is most probably mediated by a protein since a single mononucleotide would not be expected to interact strongly and specifically with a DNA molecule. With this in mind it was suggested6 that cyclic AMP triggers the synthesis of catabolite enzymes such as j3-galactosidase by interacting with the RNA polymerase. A more elaborate working hypothesis, currently favored by us, is that cyclic AMP binds to a protein subunit, which we shall call the catabolite gene activator protein (CAP), and thereby stimulates the binding of this protein subunit to RNA polymerase, producing a complex active in initiation at the promoter locus.
Detection of the CAP protein has been greatly aided by the finding of a mutant bacterial strain which appears to produce defective CAP. This mutant was obtained by Schwartz and Beckwith'0 by isolation and analysis of a number of variant strains of E. coli that could not grow on either lactose or arabinose. These variants all produce low levels of most catabolite repressible enzymes tested. Some are defective in cyclic AMP production as evidenced by their phenotypic reversion under the influence of this compound. Others are not, and one of the latter mutants has been found to be lacking a protein factor required for "turning on" the lac operon. The assignment of this defect to a protein factor has been made possible through use of the cell-free system for /-galactosidase synthesis described below.
A DNA-directed cell-free system for synthesis of lac operon proteins has been developed which contains DNA with the lac operon, a cell-free extract of E. coli, and all the cofactors and substrates essential for RNA and protein synthesis (see Methods for details). In the cell-free synthesis studies presented here two strains, 514 and X7901, have been used to produce the cell-free bacterial extracts. Both strains contain a deletion of the lac region including the repressor so that the results would not be complicated by the presence of enzymes of the lac operon or lac operon repressor at the beginning of synthesis. Strain 514 is normal in other respects and strain X7901 is the defective strain isolated by Schwartz and Beckwith (described above). In all cases the DNA used to stimulate synthesis was derived from c80dlac virus containing a normal lac operon region-a region which includes promoter, operator, structural gene for $-galcatosidase, and other structural genes of the lac operon, in that order.
In all our studies we have found that the amount of 83-galactosidase produced by the cell-free system is directly related to the amount of active lac operon present.7' 8 When the strain believed to contain the defective CAP factor is used as the source of the cell-free extract, only about 5% of the usual level of a-galactosidase is made ( Some of the physicochemical properties of the partially purified factor have been studied. The total extract has an absorption maximum in the ultraviolet at 278 m/A. The activity is completely destroyed by heating for 5 min at 600C even though longer exposures to 50'C have no effect. The size of the CAP protein has been estimated by its flow rate on G-100 Sephadex (Fig. 2) . It elutes in a volume about 60%o greater than the column exclusion volume, and bovine serum albumin of molecular weight 6 Since the CAP-containing extracts are impure, we have been concerned with the possibility that species other than the CAP are binding the cyclic AMP. Previously it had been found that cyclic GMP inhibited the cyclic AMP stimulatory effect on fl-galactosidase synthesis at comparable concentrations.7 In parallel binding studies, the level of 3H-cyclic AMP was fixed at 5 X 10-6 M and the concentration of competing nucleotide was fixed at 10-4 M. Cyclic GIMP inhibits 70% of the binding whereas either 3'-GMP or 5'-GMP have less than an 8% inhibitory effect. The parallelism between cyclic GMP in inhibiting the stimulatory action of cyclic AMP in cell-free synthesis and in inhibiting the binding of cyclic A.IP to CAP-containing extracts supports the view that most of the cyclic AMP binding in the CAP-containing extracts is due to the CAP protein itself, but it does not eliminate other possibilities. The following discussion assumes that most of the cyclic AMP binding is to the CAP.
The formation constant for the CAP-cyclic AMP complex can also be used to estimate the concentration of CAP present from the amount of bound cyclic AMIP. Only approximate calculations are possible since we do not know n, the number of cyclic AAIP binding sites per CAP molecule. Assuming n = 1 we calculate that the molarity of CAP at the point of maximum stimulation in Figure 1 is 6 X 10-8 M. This is about 35 times the molarity of the lac operon containing DNA and about twice the molarity of the RNA polymerase.12 It seems unlikely that there are many other catabolite-sensitive gene promoter sites on the 480dlac DNA. Therefore, the large excess of CAP over lac operon makes it most unlikely that CAP functions by forming a strong stoichiometric complex with the lac operon promoter. The formation of a strong stoichiometric complex between CAP and RNA polymerase is also unlikely since such an event would cause an appreciable decrease in the pool of free polymerase, thereby causing departure from linearity over the range of CAP concentrations studied in Figure 1. We conclude that CAP does not form a strong complex with either DNA or RNA polymerase. In quantitative terms, the K/s for the complexes must be less than 108. Since the hypothesized function of CAP is to trigger initiation, a complex with more than transient existence may not be needed. We are in the process of studying the interaction between CAP, RNA polymerase, and DNA by direct means; it remains to be demonstrated that CAP functions by forming such a complex.
